Fusing innovation and biotech for a more progressive tomorrow
Our advanced 89Zr crefmirlimab berdoxam (CD8 ImmunoPETTM) imaging agent and radiopharmaceutical therapy (RPT) products are aimed to enable physicians to See The Bigger Picture, and accelerate the progress of immunotherapy around the world. Join us as we reimagine a new vision and approach towards immuno oncology patient care paths. Explore more about who we are, how we innovate for tomorrow and why partnering with us will help to challenge, create and transform patient care.
Our technology uses ‘minibody’ antibodies to scan patients head-to-toe, delivering an in-depth visual profile of immunity status, before, during and after treatment.
Using our minibody and cys-diabodies platform technologies we are generating best in class RPT solutions, to kill tumor cells with targeted radiation.
At ImaginAb, everything we do is underpinned by medical expertise and scientific innovation. And our people are paramount to that.
Meet the team
